| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
23,827 |
21,043 |
$1.76M |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
28,207 |
24,582 |
$1.51M |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
8,962 |
8,831 |
$383K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
3,488 |
3,474 |
$280K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
3,090 |
3,077 |
$272K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
2,776 |
2,751 |
$226K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
2,271 |
2,239 |
$173K |
| 99395 |
Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years |
897 |
887 |
$79K |
| 92567 |
|
4,699 |
4,661 |
$51K |
| 99383 |
|
289 |
288 |
$28K |
| 95165 |
Professional services for the supervision of preparation and provision of antigens for allergen immunotherapy, multiple dose vials |
140 |
25 |
$27K |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
933 |
927 |
$22K |
| 99401 |
|
680 |
656 |
$19K |
| 99381 |
|
198 |
197 |
$17K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
490 |
480 |
$16K |
| 99384 |
|
119 |
119 |
$13K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
761 |
734 |
$10K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
97 |
97 |
$10K |
| 99173 |
|
5,110 |
5,013 |
$9K |
| 54450 |
|
134 |
132 |
$8K |
| 99000 |
|
2,676 |
2,569 |
$8K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
109 |
108 |
$8K |
| 99441 |
|
177 |
169 |
$8K |
| 81002 |
|
2,697 |
2,614 |
$7K |
| 0071A |
|
89 |
89 |
$7K |
| 0072A |
|
84 |
84 |
$7K |
| 99497 |
|
139 |
128 |
$6K |
| 99188 |
|
498 |
492 |
$5K |
| 95004 |
Percutaneous tests with allergenic extracts, immediate type reaction |
18 |
18 |
$5K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
372 |
366 |
$5K |
| 99382 |
|
48 |
48 |
$5K |
| 96127 |
|
1,125 |
1,122 |
$5K |
| 99396 |
Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years |
49 |
49 |
$4K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
303 |
277 |
$4K |
| 96160 |
|
1,542 |
1,514 |
$4K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
392 |
380 |
$3K |
| 99385 |
|
29 |
29 |
$3K |
| 94760 |
|
1,922 |
1,766 |
$2K |
| 69210 |
|
29 |
28 |
$1K |
| 99460 |
|
15 |
15 |
$1K |
| 36415 |
Collection of venous blood by venipuncture |
424 |
416 |
$998.55 |
| 90686 |
|
2,135 |
2,002 |
$956.36 |
| 95117 |
|
119 |
54 |
$883.46 |
| 99238 |
Hospital discharge day management, 30 minutes or less |
14 |
14 |
$855.98 |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
46 |
42 |
$613.10 |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
47 |
47 |
$540.00 |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
12 |
12 |
$534.52 |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
26 |
24 |
$498.90 |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
55 |
55 |
$474.74 |
| 90651 |
|
1,010 |
941 |
$370.04 |
| A4617 |
Mouth piece |
43 |
43 |
$104.35 |
| 81025 |
|
13 |
13 |
$74.21 |
| J7611 |
Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, concentrated form, 1 mg |
238 |
234 |
$46.68 |
| 90715 |
|
165 |
154 |
$34.35 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
50 |
49 |
$33.20 |
| A4616 |
Tubing (oxygen), per foot |
13 |
13 |
$1.22 |
| 90744 |
|
165 |
160 |
$0.00 |
| 90620 |
|
359 |
335 |
$0.00 |
| 90698 |
|
451 |
434 |
$0.00 |
| 90647 |
|
229 |
216 |
$0.00 |
| 90680 |
|
447 |
402 |
$0.00 |
| 90723 |
|
343 |
318 |
$0.00 |
| 90716 |
|
255 |
217 |
$0.00 |
| 90677 |
|
13 |
13 |
$0.00 |
| 36416 |
|
33 |
32 |
$0.00 |
| 90633 |
|
738 |
671 |
$0.00 |
| 90700 |
|
800 |
720 |
$0.00 |
| 90670 |
|
1,254 |
1,170 |
$0.00 |
| 90648 |
|
486 |
409 |
$0.00 |
| 90707 |
|
255 |
220 |
$0.00 |
| 90734 |
|
595 |
557 |
$0.00 |
| 90713 |
|
364 |
328 |
$0.00 |
| G9920 |
Screening performed and negative |
70 |
70 |
$0.00 |